Parallel Phase III Randomized Trials Of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (Guidance)

Parallel Phase III Randomized Trials Of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (Guidance)

Parallel Phase III Randomized Trials Of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (Guidance)

ART Trial: Phase II Randomized Trial of Atezolizumab Versus Atezolizumab and Radiation for Metastatic Urothelial Cancer. clinicaltrials.gov/ct2/show/NCT04936230

FORT Trial: Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer https://jcto.weill.cornell.edu/open_clinical_trials/randomized-trial-of-five-or-two-mri-guided-adaptive-radiotherapy-treatments-for-prostate-cancer

SHORTER Trial: Salvage Radiation for Prostate Cancer in 4 weeks vs 5 days https://jcto.weill.cornell.edu/open_clinical_trials/randomized-phase-ii-trial-of-salvage-radiotherapy-for-prostate-cancer-in-4-weeks-v-2-weeks-shorter